479 related articles for article (PubMed ID: 18083224)
1. The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2.
Lin H; Zhao Y; Sun W; Chen B; Zhang J; Zhao W; Xiao Z; Dai J
Biomaterials; 2008 Mar; 29(9):1189-97. PubMed ID: 18083224
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
3. Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide.
Chen B; Lin H; Zhao Y; Wang B; Zhao Y; Liu Y; Liu Z; Dai J
J Biomed Mater Res A; 2007 Feb; 80(2):428-34. PubMed ID: 17013862
[TBL] [Abstract][Full Text] [Related]
4. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
Behnam K; Murray SS; Brochmann EJ
Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
[TBL] [Abstract][Full Text] [Related]
5. The osteogenic effect of bone morphogenetic protein-2 on the collagen scaffold conjugated with antibodies.
Zhao Y; Zhang J; Wang X; Chen B; Xiao Z; Shi C; Wei Z; Hou X; Wang Q; Dai J
J Control Release; 2010 Jan; 141(1):30-7. PubMed ID: 19580831
[TBL] [Abstract][Full Text] [Related]
6. Quantification of various growth factors in different demineralized bone matrix preparations.
Wildemann B; Kadow-Romacker A; Haas NP; Schmidmaier G
J Biomed Mater Res A; 2007 May; 81(2):437-42. PubMed ID: 17117475
[TBL] [Abstract][Full Text] [Related]
7. Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products.
Bae HW; Zhao L; Kanim LE; Wong P; Delamarter RB; Dawson EG
Spine (Phila Pa 1976); 2006 May; 31(12):1299-306; discussion 1307-8. PubMed ID: 16721289
[TBL] [Abstract][Full Text] [Related]
8. The bone-derived collagen containing mineralized matrix for the loading of collagen-binding bone morphogenetic protein-2.
Zhao Y; Chen B; Lin H; Sun W; Zhao W; Zhang J; Dai J
J Biomed Mater Res A; 2009 Mar; 88(3):725-34. PubMed ID: 18335535
[TBL] [Abstract][Full Text] [Related]
9. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats.
Takita H; Vehof JW; Jansen JA; Yamamoto M; Tabata Y; Tamura M; Kuboki Y
J Biomed Mater Res A; 2004 Oct; 71(1):181-9. PubMed ID: 15368268
[TBL] [Abstract][Full Text] [Related]
10. Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2.
Chen B; Lin H; Wang J; Zhao Y; Wang B; Zhao W; Sun W; Dai J
Biomaterials; 2007 Feb; 28(6):1027-35. PubMed ID: 17095085
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of porous hydroxyapatite and demineralized bone matrix on bone induction: in vitro and in vivo study using a nude rat model.
Lee JH; Lee KM; Baek HR; Jang SJ; Lee JH; Ryu HS
Biomed Mater; 2011 Feb; 6(1):015008. PubMed ID: 21205997
[TBL] [Abstract][Full Text] [Related]
12. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
13. Assay of bone morphogenetic protein-2, -4, and -7 in human demineralized bone matrix.
Pietrzak WS; Woodell-May J; McDonald N
J Craniofac Surg; 2006 Jan; 17(1):84-90. PubMed ID: 16432413
[TBL] [Abstract][Full Text] [Related]
14. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex.
Chung YI; Ahn KM; Jeon SH; Lee SY; Lee JH; Tae G
J Control Release; 2007 Aug; 121(1-2):91-9. PubMed ID: 17604871
[TBL] [Abstract][Full Text] [Related]
15. Content of bone morphogenetic protein-4 in human demineralized bone: relationship to donor age and ability to induce new bone formation.
Honsawek S; Dhitiseith D
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S260-5. PubMed ID: 16623039
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of partially demineralized osteoporotic cancellous bone matrix combined with human bone marrow stromal cells for tissue engineering: an in vitro and in vivo study.
Liu G; Sun J; Li Y; Zhou H; Cui L; Liu W; Cao Y
Calcif Tissue Int; 2008 Sep; 83(3):176-85. PubMed ID: 18704250
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering.
Yilgor P; Tuzlakoglu K; Reis RL; Hasirci N; Hasirci V
Biomaterials; 2009 Jul; 30(21):3551-9. PubMed ID: 19361857
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study of the effect of new bone formation on new type artificial bone composed of bioactive ceramics].
Zhu M; Zeng Y; Sun T; Peng Q
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Mar; 19(3):174-7. PubMed ID: 15828468
[TBL] [Abstract][Full Text] [Related]
19. Effects of moisture and temperature on the osteoinductivity of demineralized bone matrix.
Han B; Yang Z; Nimni M
J Orthop Res; 2005 Jul; 23(4):855-61. PubMed ID: 16023000
[TBL] [Abstract][Full Text] [Related]
20. Effects of gamma-irradiation, storage and hydration on osteoinductivity of DBM and DBM/AM composite.
Qiu QQ; Connor J
J Biomed Mater Res A; 2008 Nov; 87(2):373-9. PubMed ID: 18181114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
